Factors determining COVID‐19 pneumonia severity in a country with routine BCG vaccination | Zendy

Aksu K. | Zendy; Naziroğlu T. | Zendy; Özkan P. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Factors determining COVID‐19 pneumonia severity in a country with routine BCG vaccination

Author(s) -

Aksu K.,

Naziroğlu T.,

Özkan P.

Publication year - 2020

Publication title -

clinical & experimental immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.329

H-Index - 135

eISSN - 1365-2249

pISSN - 0009-9104

DOI - 10.1111/cei.13507

Subject(s) - medicine , vaccination , pneumonia , odds ratio , body mass index , concomitant , population , confidence interval , immunology , pediatrics , environmental health

Sociodemographic features, body mass index, smoking status, concomitant diseases, income rates, and BCG vaccination status of subjects were analyzed in 123 patients diagnosed with COVID‐19 pneumonia in a state hospital in Istanbul, Turkey. BCG vaccination is not associated with disease severity in COVID‐19 pneumonia. Age and low income are the main determinants of severe COVID‐19 pneumonia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research